Stereotactic Ablative Radiotherapy for Management of Spinal Metastases

[TNCanuck]

TAKE-HOME MESSAGE

Spinal metastases are a source of significant pain and morbidity, especially in patients with advanced prostate cancer. This study evaluated the impact of stereotactic ablative radiotherapy (SABR) in patients with metastatic spinal lesions. In all, 59 unique publications with 5655 patients who underwent SABR for spinal metastases were included. The authors found spinal SABR was associated with 1-year local control rates of approximately 80% to 90%. The most commonly discussed adverse effect was development of a vertebral compression fracture, with incidence of 10% to 15%.

The authors conclude that spinal SABR may be an effective treatment option for certain patients with spinal metastases, with excellent local control rates and moderate rates of adverse effects. Further study, especially in the setting of oligometastatic prostate cancer, will be important to better understand biologic activity.

– Gautam Jayram, MD

Full article here:

https//practiceupdate.com/content/...

[Walkingwell]

Thank you for posting. I had this therapy for spinal mets August 2019, in line with the report, worked well, significant pain reduction. So far, so good.

[TNCanuck in reply to Walkingwell]

That's great!

[j-o-h-n in reply to Walkingwell]

Well keep Walking.............

Good Luck, Good Health and Good Humor.

j-o-h-n Monday 04/27/2020 4:29 PM DST

[Walkingwell in reply to j-o-h-n]

I am! I will! Radiotherapy was helped by my telling technicians at each session: Beam me at T7, please! (Yes, we know, they said.)

[j-o-h-n in reply to Walkingwell]

Way to go......... Congrats!!!

Good Luck, Good Health and Good Humor.

j-o-h-n Tuesday 04/28/2020 12:07 PM DST